| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 8.675 | 12.978 | 2.085 | 1.261 | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | 8.675 | 12.978 | 2.085 | 1.843 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | - | - | 4.440 | 7.339 | 6.671 | 8.536 | 6.139 | 0 | 354 | 0 |
| Gross Profit/Loss - EUR | - | - | 4.235 | 5.639 | -4.586 | -6.693 | -6.139 | 0 | -354 | 0 |
| Net Profit/Loss - EUR | - | - | 4.148 | 5.509 | -4.607 | -6.712 | -6.139 | 0 | -354 | 0 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Apteka Trade Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 989 | 969 | 951 | 930 | 933 | 930 | 925 |
| Current Assets | - | - | 4.550 | 5.245 | 196 | 902 | 1.320 | 369 | 2.050 | 2.039 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | -26 | 190 | 59 | 47 | 757 | 0 | 585 | 582 |
| Cash | - | - | 4.576 | 5.055 | 138 | 854 | 563 | 369 | 1.465 | 1.457 |
| Shareholders Funds | - | - | 44 | 5.552 | 838 | -5.890 | -11.899 | -11.935 | -12.253 | -12.184 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 4.506 | 682 | 328 | 7.743 | 14.148 | 13.238 | 15.233 | 15.148 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Apteka Trade Srl